Berger Dietmar — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Berger Dietmar has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Berger Dietmar

Dietmar Berger is a prominent executive in the pharmaceutical industry, currently serving as the Chief Medical Officer at Gilead Sciences, Inc. He has extensive experience in drug development and clinical research, contributing to the advancement of therapies in various therapeutic areas.

RoleChief Medical Officer
Notability70/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-11GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture263$121.48$32K
2026-06-11GILDGILEAD SCIENCES, INC.M — Option exercise533—
2026-03-12GILDGILEAD SCIENCES, INC.F — Tax withholding / forfeiture1.1K$148.56$158K
2026-03-12GILDGILEAD SCIENCES, INC.M — Option exercise2.1K—
2026-03-02GILDGILEAD SCIENCES, INC.A — Grant or award8.5K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Berger Dietmar?

Dietmar Berger is a prominent executive in the pharmaceutical industry, currently serving as the Chief Medical Officer at Gilead Sciences, Inc. He has extensive experience in drug development and clinical research, contributing to the advancement of therapies in various therapeutic areas.…

How many SEC Form 4 filings has Berger Dietmar submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Berger Dietmar's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Berger Dietmar profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.